UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000016719 |
|---|---|
| Receipt number | R000019400 |
| Scientific Title | Surveillance for patients' satisfaction after chemotherapy registered nurse system introduced |
| Date of disclosure of the study information | 2015/03/12 |
| Last modified on | 2015/03/05 18:22:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Surveillance for patients' satisfaction after chemotherapy registered nurse system introduced
Acronym
Surveillance for patients' satisfaction after chemotherapy registered nurse system introduced
Scientific Title
Surveillance for patients' satisfaction after chemotherapy registered nurse system introduced
Scientific Title:Acronym
Surveillance for patients' satisfaction after chemotherapy registered nurse system introduced
Region
| Japan |
Condition
Condition
Cancer patients
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
In our hospital, only trained chemotherapy registered nurses secured peripheral venous access in outpatient chemotherapy center in the past. To improve patient services and reduce doctors' duties, we started chemotherapy registered nurse system for inpatients, too. To survey patients' satisfaction for the system, we will conduct a a questionnaire survey and evaluate the system.
Basic objectives2
Others
Basic objectives -Others
a questionnaire survey(The surveillance of patients' satisfaction)
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To survey patients satisfaction for the duration of chemotherapy, the technique of peripheral venous cannulation, the pain of venous cannulation, and the care for the treatment.
Key secondary outcomes
To improve the system, we use the comment written in the questionnaires.
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Single blind -investigator(s) and assessor(s) are blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Other |
Interventions/Control_1
a questionnaire survey
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 95 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients admitted to our hospital ward first time, received peripheral venous cannulation by chemotherapy registered nurses, and agreed our study.
Key exclusion criteria
Patients readmitted, received chemotherapy with central venous catheter, and denied our study.
Target sample size
150
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Mika Tsunogi |
Organization
Hyogo Cancer Center
Division name
Department of nursing
Zip code
Address
13-70 Kitaoji-cho, Akashi-City, Hyogo 673-8558, Japan
TEL
078-929-1151
mika-tng175@umin.org
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Mika Tsunogi |
Organization
Hyogo Cancer Center
Division name
Department of nursing
Zip code
Address
13-70 Kitaoji-cho, Akashi-City, Hyogo 673-8558, Japan
TEL
078-929-1151
Homepage URL
mika-tng175@umin.org
Sponsor or person
Institute
Hyogo Cancer Center
Institute
Department
Personal name
Funding Source
Organization
No fund
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 03 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2015 | Year | 02 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 03 | Month | 12 | Day |
Last follow-up date
| 2016 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2015 | Year | 03 | Month | 05 | Day |
Last modified on
| 2015 | Year | 03 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019400
